news

insights

events

rankings

Speaking Engagements

• Mentioned in The Daily Journal and Law360 regarding Viking Therapeutics, Inc.'s initial public offering

• Mentioned in The Recorder, The Daily Journal and Law360 regarding representing Kosei, Inc. its its sale to Pinterest, Inc.

• Cheaper, Stronger IPOs Still Elusive After JOBS Act360

• RR Donnelley presents to SEC Hot Topics Institute, San Diego, CA

• Alliance Advisors, Society of Corporate Secretaries & Governance Professionals and Paul Hastings LLPpresent ISS Proxy Voting Guidelines, Chicago, IL

• Society of Corporate Secretaries and Governance Professionals Presents Hot Issues in Private Company Governance, Colorado Springs, CO

• RR Donnelley presents the SEC Hot Topics Institute, San Diego, CA

• Paul Hastings, Citadel Securities, PricewaterhouseCoopers, MacKenzie Partners and RR Donnelley Present a Briefing on Proxy Access, Executive Compensation and Corporate Governance under the Dodd-Frank (Wall Street Reform) Act:

• Paul Hastings, Houlihan Lokey, BDO Seidman and Thomas Weisel Partners Present a Briefing on Registered Direct and At-the-Market Equity Offerings: Trends for Raising Capital in 2010, Los Angeles, CA

• RR Donnelley presents the SEC Hot Topics Institute, San Diego, CA

• Stafford Publications presents: A Roadmap to Emerging Financing Alternatives Leveraging Opportunities in Rights Offerings, Registered Directs, and More

• Houlihan Lokey, Paul Hastings and Sagient/PlacementTracker Present an Interactive Webinar: PIPEs: The Ever-Evolving Financing Technique

Involvement

• Member of the Board of Directors of the National Kidney Foundation of Northern California

• Member of the California State Bar Association

• Member of the Committee on Federal Regulation of Securities of the American Bar Association

Recent Representations

• Alpha Teknova, Inc. in its initial public offering

• Hero Research, Inc. in its sale to People.ai

• Jasper Therapeutics, Inc. in its reverse merger (deSPAC) with Amplitude Healthcare Acquisition Corporation

• Seqster PDM in its preferred stock financing

• River Financial in its preferred stock financing

• Masimo Corporation in its acquisition of LiDCO Group Plc

• Paige.ai, Inc. in its preferred stock financing

• Orphion Therapeutics, Inc. in its preferred stock financing

• Aterian, Inc. in its acquisitions of Truweo and various e-commerce business brands

• Valente Sherman, Inc. (VISO Trust) in its preferred stock financing

• Zycada Networks, Inc. in its preferred stock financing

• Sorrento Therapeutics, Inc. in its acquisitions of ACEA Therapeutics, Inc. and SmartPharm Therapeutics, Inc.

• Indapta Therapeutics, Inc. in its financing transactions

• Kasha Global Inc. in its preferred stock financing

• Jasper Therapeutics, Inc. in its preferred stock financing

• kimkim, Inc. in its financing transaction

• DerivaDEX in its financing transaction

• Masimo Corporation in its acquisition of the Connected Care Business from NantHealth, Inc.

• Polychain Capital in its investments

• CareDx, Inc. in its acquisitions of TransChart, XynManagement, Inc. and OTTR

• Veriflow Systems, Inc. in its sale to VMware, Inc.

• PredictImmune Ltd. in its preferred stock financing

• Mohawk Group Holdings in its initial public offering and additional financings

• Scilex Holding Company in its acquisition of Semnur Pharmaceuticals, Inc.

• selectION, Inc. in its preferred stock financing

• Aardvark Therapeutics, Inc. in its preferred stock financings

• Neubase Therapeutics, Inc. in its reverse merger with Ohr Pharmaceutical, Inc. and financing transactions

• OneStream Software LLC in its financing by KKR

• Zededa, Inc. in its preferred stock financings

• Oasis Labs in its financings and corporate matters

• Scilex Pharmaceuticals Inc. in its debt financing structured by Morgan Stanley

• Integrated DNA Technologies in its sale to Danaher

• Seelos Therapeutics, Inc. in its reverse merger with Apricus Biosciences, Inc. and financings

• BlastWave,Inc. in its preferred stock financing

• Hummingbird Regtech, Inc. in its preferred stock financings

• healthblock, Inc. in its financing led by XSeed Capital

• Integrated DNA Technologies, Inc. in its sale to Danaher Corporation

• Shift Financial, Inc. in its merger with Ledge, Inc.

• Mobile Gaming Technologies in its partnership with Arsenal Football Club

• Redmile Group, LLC in its preferred stock financing of Alder BioPharmaceuticals, Inc.

• Sorrento Therapeutics, Inc. and TNK Therapeutics, Inc. in their joint venture with Celularity, Inc.

• Corsair Components in its sale to EagleTree Capital

• Darmiyan, Inc. in its financing transactions

• Mission Bio, Inc. in its venture-backed financing transactions

• Integrated DNA Technologies, Inc. in its partnership with Illumina

• TNK Therapeutics, Inc. in its acquisition of Virttu Biologics

• Sorrento Therapeutics, Inc. in its underwritten public offerings

• Tapclicks, Inc. in its debt financing by SaaS Capital

• J.T. Posey Company in its sale to RoundTable Healthcare Partners

• Biopop in its sale to Intrexon Corporation

• Enplas America, Inc. in its equity and debt investments

• Matrix Industries, Inc. in its equity and debt financing transactions

• Eprazel, Inc. in its strategic financing by Renren, Inc.

• Sorrento Therapeutics, Inc. in its acquisition of Scilex Pharmaceuticals Inc.

• Seelos Therapeutics, Inc. in its licensing transaction with Ligand Pharmaceuticals Incorporated

• CareDx, Inc. in its underwritten public offerings and its stock option exchange program

• GenapSys, Inc. in its preferred stock and debt financing transactions

• Veriflow Systems, Inc. in its financing by Menlo Ventures and New Enterprise Associates (NEA)

• Samumed, LLC in its financing transactions

• SMA Solar Technology AG in its investment in Tigo Energy, Inc.

• Filld, Inc. in its financings by Lightspeed Partners, Javelin Partners and PivotNorth

• Plum, Inc. in its strategic financing by Renren, Inc.

• Procera Networks, Inc. in its sale to Francisco Partners

• Viking Therapeutics, Inc. in its initial public offering, follow-on public offerings and equity line financing

• Kosei, Inc. in its sale to Pinterest, Inc.

• Boomtown Networks, Inc. in its strategic financings

• Sorrento Therapeutics, Inc. in its joint venture with NantWorks and financing transactions

• RightSignature LLC in its sale to Citrix Systems

• Integrated DNA Technologies, Inc. in the strategic financing by Summit Partners

• Samsung Electronics Co., Ltd. in the sale of its joint venture stake to, and strategic investment in, Corning Incorporated

• Fox Factory in its initial public offering

• YFind Technologies Private Limited in its sale to Ruckus Wireless, Inc.

• Corsair Components, Inc. in the strategic financing by Francisco Partners and its acquisition of Simple Audio Limited

• Procera Networks, Inc. in its acquisition of Vineyard Networks Inc.

• The underwriters, led by Goldman, Sachs & Co. and Deutsche Bank Securities, in the initial public offering of Envivio, Inc.

• Monitise plc in its acquisition of ClairMail, Inc.

• Samsung Electronics Co., Ltd. in the sale of its hard disk-drive unit to Seagate Technology

• Masimo Corporation in its acquisitions of Phasein AB and Spire Semiconductor, LLC

• Exceptional Cloud Services in its sale to Rackspace Hosting, Inc.

• Samsung Electronics, Co., Ltd. in its acquisition of Nexus Dx

• Houlihan Lokey as exclusive dealer-manager for Network Communications, Inc.'s senior notes exchange offer, consent solicitation and balance sheet restructuring

• Hanwha Chemical in its strategic investment in Solarfun Power Holdings

• Mint Software, Inc. (mint.com) in its sale to Intuit, Inc.

• Sybase, Inc. in its 144A-for-life convertible notes offering

• AviaraDx, Inc. in its sale to bioMerieux

• Masimo Corporation in its initial public offering

• Warburg Pincus in its exchangeable bond investment in Synutra International, Inc.

• CryoCor, Inc. in its initial public offering

• The Titan Corporation in its acquisition of Jaycor, Inc. in a stock-for-stock merger

• Favrille, Inc. in its initial public offering

• MannKind Corporation in its initial public offering

• Applied Micro Circuits Corporation in its acquisition of JNI Corporation

• Woodside Biomedical, Inc. in its sale to Abbott Laboratories